Forsyth Medical Center Go

Previous studies

Novant Health Clinical Research has conducted over 200 studies since 2003. These include Phase II through Phase IV device and drug studies in both the outpatient and inpatient setting. Novant Health's robust data warehouse enables internal analysis of aggregate data to present an accurate estimate of study populations. Our recent move to EPIC EMR allows for HIPAA-compliant screening of research population.

Previous studies include Across Cypher, Act I, ACUITY, Amethyst, APPRACH, APPROPRIATE, Ascend HF, ATTRACT, AWARE, BARRICADE, CABANA, CAPTURE II, CLEVER, CREST, Crystal AF, C-STARR, CURRENT OASIS, DESIRABLE, Early ACS, ENDEAVOR III, ENDEAVOR IV, EXACT, EXAMINE, FREEDOM, FUSION II, GREAT, HF ACTION, HOPE4HF, IMPROVE IT, INTENSE, MAVRIC, MCAT, MOSAIC, NAPA 3, OCEANS, OMNI, OPTIMIZER, OPTIONS, PEARL, PEARL II, PEDAL, TIMI 30, 38, 50, 54, Penumbra 054, Periscope, PERSEUS, PLATO, PREVENT IV, PREVENT HIT, PRIDE, PROMISE, PROTECT II, REDUCE HF, Replica, RESOLUTE, SAPPHIRE, SEPIA, Shock-Less, SPIRIT IV, SPIRIT PRIME, STABLE, STEEPLE, SYMBIOTT, TAXUS (series), TEAM HF, Tele-HF, TOPCAT, TRILOGY, TRIUMPH, VIRGO, VITALITY, WARCEF, XIENCE V, ZOMAXX II, and others.

Five Recent Studies

Study Indication Goal Enrollment
Spirit IV Coronary occlusion 52 38
Sapphire Carotid artery disease 56 107
Endeavor IV Coronary occlusion 29 20
Crest Carotid artery disease 43 40
Rheos Uncontrolled Hypertension 5 7